|
|
 |
February 8, 2008 PRESS RELEASE Clifton Mining Company Inc. (OTC : CFTN) ABL SIGNS INTERNATIONAL JOINT VENTURE American Biotech Labs (ABL), a private company (Clifton Mining Company owns 22% of ABL) announces that they have just signed a joint venture with International Minerals and Metals, Inc. (IMM), to develop markets in 59 countries. The New Venture IMM is a private international company that has built a longstanding network of joint ventures in 59 countries, under the direction of its chairman Mr. Philip M. Lynch. This joint venture network will become the basis for the next round of sales growth for ABL as well as for humanitarian aid purposes. Over the last year, the management of ABL has personally met with many of these joint venture partners in Dubai, Singapore, China, India, and Europe, etc., in preparation for the new ABL/IMM joint venture. Management Comment The management of ABL feels that this joint venture will open doors in numerous countries world wide, where the SilverSol Technology™ products are needed, to promote health and wellness. Clifton trades on the U.S. OTC: (CFTN). For additional information, contact Dr. Ken Friedman, President at 303-642-0659, Keith Moeller Vice President at 801-756-1414 or see our website at www.cliftonmining.com ### Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company’s business prospects and performance. |
